Teva Pharmaceutical Industries (TEVA)
(Delayed Data from NYSE)
$16.55 USD
+0.21 (1.29%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $16.57 +0.02 (0.12%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Top 41% (104 out of 249)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.44 | 1.42 | 9.99 |
Current Quarter Estimate | 0.57 | 1.25 | 61.00 |
Year Ago Quarter Estimate | 0.56 | -4.28 | 54.84 |
Next Quarter Estimate | 0.61 | 1.37 | 63.00 |
Next Year Estimate | 2.72 | 7.08 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -4.30 | 10.70 | 15.67 |
Next Year | 11.02 | 14.40 | 9.31 |
Last 5 Years | -4.00 | 0.10 | 8.10 |
Next 5 Years | 4.60 | 13.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 6.19 | 1.64 |
Price/Book (MRQ) | 2.45 | 1.28 |
Price/Cash Flow (MRFY) | 4.64 | 10.50 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -2.88% | NA |
Return on Equity (TTM) | 37.33% | NA |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.